Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Fruehauf

Showing results (31-40 of 60) with videos related to

Pageof 6
Sort By:
International Journal of Radiation Oncology, Biology, Physics|December 21, 2000
Prospective evaluation of delayed central nervous system (CNS) toxicity of hyperfractionated total body irradiation (TBI)F Wenz, S Steinvorth, F Lohr, et al.
Clinical and Experimental Immunology|December 2, 2008
Enhanced complement resistance in drug-selected P-glycoprotein expressing multi-drug-resistant ovarian carcinoma cellsK E Odening, W Li, R Rutz, et al.
Blood|June 15, 1995
Sustained long-term hematopoiesis after myeloablative therapy with peripheral blood progenitor cell supportR Haas, B Witt, R Möhle, et al.
Gene Therapy|October 30, 2009
Chemoprotection of human hematopoietic stem cells by simultaneous lentiviral overexpression of multidrug resistance 1 and O(6)-methylguanine-DNA methyltransferase(P140K)P Maier, I Spier, S Laufs, et al.
Bone Marrow Transplantation|August 10, 2000
Human multidrug resistance-1 gene transfer to long-term repopulating human mobilized peripheral blood progenitor cellsB Schiedlmeier, K Wermann, K Kühlcke, et al.
Cytotherapy|December 7, 2006
Retroviral MDR1 gene transfer into marrow-engrafting human peripheral blood progenitor cells results in preferential transgene expression in the immature myeloid compartment rather than in mature myeloid progeny in vivoE C Buss, S Laufs, S Naundorf, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|September 26, 1997
Protection of hematopoietic stem cells from chemotherapy-induced toxicity by multidrug-resistance 1 gene transferS Fruehauf, K Wermann, E C Buss, et al.
Journal of Leukocyte Biology|April 26, 2003
Imatinib restores expression of CD62L in BCR-ABL-positive cellsS Fruehauf, J Topaly, M Schad, et al.
British Journal of Haematology|June 20, 1998
The dose of granulocyte colony-stimulating factor administered following cytotoxic chemotherapy is not related to the rebound level of circulating CD34+ haemopoietic progenitor cells during marrow recoveryS Martin-Murea, M T Voso, S Hohaus, et al.
British Journal of Haematology|June 3, 1999
Peripheral blood progenitor cell (PBPC) counts during steady-state haemopoiesis enable the estimation of the yield of mobilized PBPC after granulocyte colony-stimulating factor supported cytotoxic chemotherapy: an update on 100 patientsS Fruehauf, K Schmitt, M R Veldwijk, et al.
Pageof 6

Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
International Journal of Radiation Oncology, Biology, Physics|December 21, 2000
Prospective evaluation of delayed central nervous system (CNS) toxicity of hyperfractionated total body irradiation (TBI)F Wenz, S Steinvorth, F Lohr, et al.
Clinical and Experimental Immunology|December 2, 2008
Enhanced complement resistance in drug-selected P-glycoprotein expressing multi-drug-resistant ovarian carcinoma cellsK E Odening, W Li, R Rutz, et al.
Blood|June 15, 1995
Sustained long-term hematopoiesis after myeloablative therapy with peripheral blood progenitor cell supportR Haas, B Witt, R Möhle, et al.
Gene Therapy|October 30, 2009
Chemoprotection of human hematopoietic stem cells by simultaneous lentiviral overexpression of multidrug resistance 1 and O(6)-methylguanine-DNA methyltransferase(P140K)P Maier, I Spier, S Laufs, et al.
Bone Marrow Transplantation|August 10, 2000
Human multidrug resistance-1 gene transfer to long-term repopulating human mobilized peripheral blood progenitor cellsB Schiedlmeier, K Wermann, K Kühlcke, et al.
Cytotherapy|December 7, 2006
Retroviral MDR1 gene transfer into marrow-engrafting human peripheral blood progenitor cells results in preferential transgene expression in the immature myeloid compartment rather than in mature myeloid progeny in vivoE C Buss, S Laufs, S Naundorf, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|September 26, 1997
Protection of hematopoietic stem cells from chemotherapy-induced toxicity by multidrug-resistance 1 gene transferS Fruehauf, K Wermann, E C Buss, et al.
Journal of Leukocyte Biology|April 26, 2003
Imatinib restores expression of CD62L in BCR-ABL-positive cellsS Fruehauf, J Topaly, M Schad, et al.
British Journal of Haematology|June 20, 1998
The dose of granulocyte colony-stimulating factor administered following cytotoxic chemotherapy is not related to the rebound level of circulating CD34+ haemopoietic progenitor cells during marrow recoveryS Martin-Murea, M T Voso, S Hohaus, et al.
British Journal of Haematology|June 3, 1999
Peripheral blood progenitor cell (PBPC) counts during steady-state haemopoiesis enable the estimation of the yield of mobilized PBPC after granulocyte colony-stimulating factor supported cytotoxic chemotherapy: an update on 100 patientsS Fruehauf, K Schmitt, M R Veldwijk, et al.
Pageof 6